We noticed that lncRNA DRAIC had the most significant effect in predicting the prognosis of patients after receiving radiotherapy; lncRNA DRAIC has been shown to inhibit the progression of prostate cancer by interacting with IκB kinase (IKK) and inhibiting NF-κB activity (43). This evidence concerns the gene NFKB1 and prostate carcinoma.